Phase 1/2 Study of Vorinostat in Combination With Radiation Therapy and Infusional 5-FU in Patients With Locally Advanced Adenocarcinoma of the Pancreas.
Phase of Trial: Phase I/II
Latest Information Update: 12 May 2017
At a glance
- Drugs Vorinostat (Primary) ; Fluorouracil
- Indications Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- 30 Mar 2017 Status changed from active, no longer recruiting to discontinued.
- 19 Jul 2011 Planned End Date changed from 1 Jul 2011 to 1 Aug 2013 as reported by ClinicalTrials.gov.
- 19 Jul 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.